Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine A Murphy

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Physiology (Bethesda, Md.)|August 9, 2022
Signaling through Free Fatty Acid Receptor 4 Attenuates Cardiometabolic DiseaseTimothy D O'Connell, Katherine A Murphy, Naixin Zhang, et al.
ACS Nano|May 25, 2018
Eradication of Established Tumors by Chemically Self-Assembled Nanoring Labeled T CellsJacob R Petersburg, Jingjing Shen, Clifford M Csizmar, et al.
Frontiers in Immunology|September 9, 2020
Polymicrobial Sepsis Impairs Antigen-Specific Memory CD4 T Cell-Mediated ImmunityFrances V Sjaastad, Tamara A Kucaba, Thamotharampillai Dileepan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 3, 2013
CD8+ T cell-independent tumor regression induced by Fc-OX40L and therapeutic vaccination in a mouse model of gliomaKatherine A Murphy, Jami R Erickson, Charles S Johnson, et al.
The FEBS Journal|October 2, 2015
Triptolide enhances the tumoricidal activity of TRAIL against renal cell carcinomaErik L Brincks, Tamara A Kucaba, Britnie R James, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2018
Cutting Edge: Elevated Leptin during Diet-Induced Obesity Reduces the Efficacy of Tumor ImmunotherapyKatherine A Murphy, Britnie R James, Frances V Sjaastad, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 23, 2013
Immunogenicity of murine solid tumor models as a defining feature of in vivo behavior and response to immunotherapyMelissa G Lechner, Saman S Karimi, Keegan Barry-Holson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2012
An in vivo immunotherapy screen of costimulatory molecules identifies Fc-OX40L as a potent reagent for the treatment of established murine gliomasKatherine A Murphy, Melissa G Lechner, Flavia E Popescu, et al.
Frontiers in Immunology|November 16, 2018
Polymicrobial Sepsis Chronic Immunoparalysis Is Defined by Diminished Ag-Specific T Cell-Dependent B Cell ResponsesFrances V Sjaastad, Stephanie A Condotta, Jessica A Kotov, et al.
Current Biology : CB|November 20, 2020
CK2 Inhibits TIMELESS Nuclear Export and Modulates CLOCK Transcriptional Activity to Regulate Circadian RhythmsYao D Cai, Yongbo Xue, Cindy C Truong, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Physiology (Bethesda, Md.)|August 9, 2022
Signaling through Free Fatty Acid Receptor 4 Attenuates Cardiometabolic DiseaseTimothy D O'Connell, Katherine A Murphy, Naixin Zhang, et al.
ACS Nano|May 25, 2018
Eradication of Established Tumors by Chemically Self-Assembled Nanoring Labeled T CellsJacob R Petersburg, Jingjing Shen, Clifford M Csizmar, et al.
Frontiers in Immunology|September 9, 2020
Polymicrobial Sepsis Impairs Antigen-Specific Memory CD4 T Cell-Mediated ImmunityFrances V Sjaastad, Tamara A Kucaba, Thamotharampillai Dileepan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 3, 2013
CD8+ T cell-independent tumor regression induced by Fc-OX40L and therapeutic vaccination in a mouse model of gliomaKatherine A Murphy, Jami R Erickson, Charles S Johnson, et al.
The FEBS Journal|October 2, 2015
Triptolide enhances the tumoricidal activity of TRAIL against renal cell carcinomaErik L Brincks, Tamara A Kucaba, Britnie R James, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2018
Cutting Edge: Elevated Leptin during Diet-Induced Obesity Reduces the Efficacy of Tumor ImmunotherapyKatherine A Murphy, Britnie R James, Frances V Sjaastad, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 23, 2013
Immunogenicity of murine solid tumor models as a defining feature of in vivo behavior and response to immunotherapyMelissa G Lechner, Saman S Karimi, Keegan Barry-Holson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2012
An in vivo immunotherapy screen of costimulatory molecules identifies Fc-OX40L as a potent reagent for the treatment of established murine gliomasKatherine A Murphy, Melissa G Lechner, Flavia E Popescu, et al.
Frontiers in Immunology|November 16, 2018
Polymicrobial Sepsis Chronic Immunoparalysis Is Defined by Diminished Ag-Specific T Cell-Dependent B Cell ResponsesFrances V Sjaastad, Stephanie A Condotta, Jessica A Kotov, et al.
Current Biology : CB|November 20, 2020
CK2 Inhibits TIMELESS Nuclear Export and Modulates CLOCK Transcriptional Activity to Regulate Circadian RhythmsYao D Cai, Yongbo Xue, Cindy C Truong, et al.
Pageof 3